Overview
MK0476 Study in Adult Patients With Acute Asthma (0476-322)
Status:
Completed
Completed
Trial end date:
2007-06-01
2007-06-01
Target enrollment:
0
0
Participant gender:
All
All
Summary
This study evaluates the efficacy and safety of MK0476 intravenous administration in adult patients with acute asthma.Phase:
Phase 3Accepts Healthy Volunteers?
NoDetails
Lead Sponsor:
Merck Sharp & Dohme Corp.Treatments:
Montelukast
Criteria
Inclusion Criteria:- Adult Patients With Acute Asthma Attacks
Exclusion Criteria:
- Patient Has Any Known Or Suspected, Acute Or Chronic Cause For Their Pulmonary
Symptoms Other Than Asthma (E.G., Copd, Chronic Heart Failure, Etc.)
- Patient Has A Smoking History (20 Cigarettes Per Day) Of More Than 15 Years
- Patient Has A Disease Of The Cardiovascular, Hepatic, Renal, Hematologic Systems, Or
Other Severe Disease